GPR132-knockdown AML cells had much lower expression levels of CD11b (Supplemental Fig. S9D, E), which was consistent with the increased number of undifferentiated blast cells upon GPR132 knockdown as evaluated by Wright-Giemsa staining (Supplemental Fig. S9F, G). Here, GPR132 is linked to acute myeloid leukemia.